Dama Health Secures Seed Funding: Advancing Personalized Medicine in Women's Reproductive Health

Dama Health, an innovative leader in personalized and precision medicine tailored specifically for women's reproductive health, is proud to announce its recent funding achievement.

The company has successfully secured a substantial amount to further its mission of empowering women, and individuals assigned female at birth, by enhancing their reproductive health choices, starting with contraception.

The Dama Health Digital Platform stands out as a pioneering solution, providing both healthcare providers and patients with personalized consultations that prioritize safety and effectiveness in contraceptive methods and ob-gyn decisions.

This new funding will be instrumental in expanding the platform's capabilities, allowing Dama Health to refine its technology and improve user experience while increasing accessibility for all.

Backed by reputable organizations such as Illumina for Start-ups and the KQ Labs 2022-23 cohort, Dama Health is well-positioned to lead the charge in revolutionizing women's reproductive health care.

By continuing to innovate and invest in research, the company aims to develop a data-driven approach to contraception that takes into account individual needs and circumstances, ultimately supporting healthier choices and better outcomes for women.

With this new investment, Dama Health is set to further its commitment to transforming women's healthcare and ensuring every individual has the information and resources they need to make informed decisions about their reproductive health.